Comprehensive clinical phenotype, genotype and therapy in Yao syndrome

Yao syndrome (YAOS) is formerly called nucleotide-binding oligomerization domain containing 2 ( -associated autoinflammatory disease.We report a large cohort of YAOS. We conducted a retrospective analysis of a cohort of adult patients with systemic autoinflammatory diseases (SAIDs). All patients und...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2024-09, Vol.15, p.1458118
Hauptverfasser: Nomani, Hafsa, Wu, Song, Saif, Ashmia, Hwang, Frank, Metzger, Jane, Navetta-Modrov, Brianne, Gorevic, Peter D, Aksentijevich, Ivona, Yao, Qingping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Yao syndrome (YAOS) is formerly called nucleotide-binding oligomerization domain containing 2 ( -associated autoinflammatory disease.We report a large cohort of YAOS. We conducted a retrospective analysis of a cohort of adult patients with systemic autoinflammatory diseases (SAIDs). All patients underwent testing for a periodic fever syndrome gene panel. A total of 194 patients carried variants, 152 patients were diagnosed with YAOS, and 42 had mixed autoinflammatory diseases with combined variants in and other SAID-associated genes. Demographic, clinical and molecular data were summaried. In sub-group analysis of the 194 patients, individual patients were often identified to carry two or more variants that usually included IVS8 + 158/R702W, IVS8 + 158/L1007fs, IVS8 + 158/V955I, IVS8 + 158/other, or variants in other SAID genes. Ninety-nine patients carried single variants. Taken together, these variants contribute to the disease in combination or individually. This largest cohort has provided comprehensive clinical and genotyping data in YAOS. Variants in the gene can give rise to a spectrum from inflammatory bowel disease to autoinflammatory disease.This report further raises awareness of the underdiagnosed disease in the medical community.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1458118